Derralynn Hughes

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 556 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping

Daniel Sado, Steven K White, Stefan K. Piechnik et al. · Circulation Cardiovascular Imaging · 2013 · 530 citations · Full text

Medicine, Cardiology, Radiology +17

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Maarten Arends, Christoph Wanner, Derralynn Hughes et al. · Journal of the American Society of Nephrology · 2016 · 421 citations · Full text

Veterinary Medicine, Cardiology, Clinical Sciences +9

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder–Plassmann et al. · Journal of Medical Genetics · 2016 · 386 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

Daniel Sado, Andrew Flett, Sanjay M Banypersad et al. · Heart · 2012 · 359 citations · Full text

Medicine, Cardiology, Radiology +17